TECH

BIO-TECHNE Corp

US StockNASDAQBiological Products, (No Diagnostic Substances)

Research the business. Follow the filings.

Financial information from SEC disclosures, with reporting periods kept in context.

Revenue

1.2B USDAnnual · FY 2026

Operating income

251.9M USDAnnual · FY 2026

Net income

73.4M USDAnnual · FY 2025

Total assets

2.6B USDAnnual · FY 2026

Equity

2.1B USDAnnual · FY 2026

Operating cash flow

292.1M USDAnnual · FY 2026

TECH · Chart

Chart provided by TradingView. Loading the chart connects your browser to TradingView and sends necessary technical information such as your IP address, page URL, and displayed symbol.

Reported financial information

Revenue

USD

1.2B USD

Period data
PeriodValue
FY 20221.1B USD
FY 20231.1B USD
FY 20241.2B USD
FY 20251.2B USD
FY 20261.2B USD

Operating income

USD

251.9M USD

Period data
PeriodValue
FY 2022296.6M USD
FY 2023298.9M USD
FY 2024206.7M USD
FY 2025102.3M USD
FY 2026251.9M USD

Net income

USD

73.4M USD

Period data
PeriodValue
FY 2021140.4M USD
FY 2022272.1M USD
FY 2023285.3M USD
FY 2024168.1M USD
FY 202573.4M USD

Total assets

USD

2.6B USD

Period data
PeriodValue
FY 20222.3B USD
FY 20232.6B USD
FY 20242.7B USD
FY 20252.6B USD
FY 20262.6B USD

Equity

USD

2.1B USD

Period data
PeriodValue
FY 20221.7B USD
FY 20232B USD
FY 20242.1B USD
FY 20251.9B USD
FY 20262.1B USD

Operating cash flow

USD

292.1M USD

Period data
PeriodValue
FY 2022325.3M USD
FY 2023254.4M USD
FY 2024299M USD
FY 2025287.6M USD
FY 2026292.1M USD

Revenue growth

%

-0.4%

Period data
PeriodValue
FY 202218.7%
FY 20232.8%
FY 20242%
FY 20255.2%
FY 2026-0.4%

Operating income growth

%

146.3%

Period data
PeriodValue
FY 202225%
FY 20230.8%
FY 2024-30.9%
FY 2025-50.5%
FY 2026146.3%

Net income growth

%

-56.3%

Period data
PeriodValue
FY 2021-38.8%
FY 202293.8%
FY 20234.9%
FY 2024-41.1%
FY 2025-56.3%

Operating margin

%

20.7%

Period data
PeriodValue
FY 202226.8%
FY 202326.3%
FY 202417.8%
FY 20258.4%
FY 202620.7%

Net margin

%

6%

Period data
PeriodValue
FY 202115.1%
FY 202224.6%
FY 202325.1%
FY 202414.5%
FY 20256%

Return on assets

%

2.8%

Period data
PeriodValue
FY 20216.5%
FY 202211.9%
FY 202311.6%
FY 20246.3%
FY 20252.8%

Debt/Equity

x

No applicable data available

Period data
PeriodValue
FY 2022N/A
FY 2023N/A
FY 2024N/A
FY 2025N/A
FY 2026N/A